Nkarta, Inc. Payments for Restructuring
Nkarta, Inc. (NKTX) reported Payments for Restructuring of $145.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2026-08-10
- Nkarta, Inc. payments for restructuring for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Nkarta, Inc. payments for restructuring for the quarter ending 2026-03-31 was $145.00K, a 92.09% decline year-over-year.
- Nkarta, Inc. payments for restructuring for the quarter ending 2025-09-30 was $671.00K.
- Nkarta, Inc. payments for restructuring for the quarter ending 2025-06-30 was $1.83M.
- Nkarta, Inc. payments for restructuring for fiscal 2025 was $4.80M.
- Nkarta, Inc. payments for restructuring for fiscal 2023 was $800.00K.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $145.00K 10-Q · filed 2026-08-10 | ||
| 2026-03-31 | $145.00K 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | $4.80M 10-K · filed 2026-03-25 | |||
| 2025-09-30 | $671.00K 10-Q · filed 2025-11-10 | $2.50M derived: sum of 2 quarters · filed 2026-08-10 | $4.34M derived: sum of 3 quarters · filed 2026-08-10 | |
| 2025-06-30 | $1.83M 10-Q · filed 2026-08-10 | $3.67M derived: sum of 2 quarters · filed 2026-08-10 | ||
| 2025-03-31 | $1.83M 10-Q · filed 2026-08-10 | |||
| 2023-12-31 | $800.00K 10-K · filed 2025-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |